• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS HBA1C III TINA-QUANT HEMOGLOBIN A1C III; ASSAY, GLYCOSYLATED HEMOGLOBIN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS HBA1C III TINA-QUANT HEMOGLOBIN A1C III; ASSAY, GLYCOSYLATED HEMOGLOBIN Back to Search Results
Model Number HBA1C TQ G3
Device Problem Low Test Results (2458)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 02/02/2020
Event Type  malfunction  
Manufacturer Narrative
This event occurred in (b)(6).
 
Event Description
The initial reporter stated they received discrepant results for one patient sample tested with a1c-3 tina-quant hemoglobin a1c gen.3 on a cobas 4000 c (311) stand alone system.The sample resulted with an hba1c value of 4.1 % when tested on the customer's c 311 analyzer and this value was reported outside of the laboratory.The sample was sent to another laboratory for testing with an unknown method, resulting with an hba1c value of 6.2 %.All measurements performed on the c 311 analyzer repeat with the same value initially obtained on the c 311 analyzer.The serial number of the customer's c 311 analyzer is (b)(4).
 
Manufacturer Narrative
Upon review of the calibration data, frequent sensitivity errors were observed and this is abnormal.This alarm is indicated if the sensitivity value obtained in a calibration falls out of the sensitivity limits specified in the analyzer settings for the test.Upon review of control data, high imprecision was observed.The instrument is not performing as expected.Based on alarm trace information, the customer maintenance is not being performed according to instructions.The sample probe was bent and this was determined to be the root cause of the issue.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HBA1C III TINA-QUANT HEMOGLOBIN A1C III
Type of Device
ASSAY, GLYCOSYLATED HEMOGLOBIN
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
MDR Report Key9745665
MDR Text Key220292660
Report Number1823260-2020-00533
Device Sequence Number1
Product Code LCP
Combination Product (y/n)N
PMA/PMN Number
K102914
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup
Report Date 03/12/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/24/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/31/2020
Device Model NumberHBA1C TQ G3
Device Catalogue Number05336163190
Device Lot Number38625601
Was Device Available for Evaluation? Yes
Date Manufacturer Received02/06/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-